|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Deferred offering costs - Note 3 | ||||||||||||||||||||
| Due from Axiom | ||||||||||||||||||||
| Due from related party | ||||||||||||||||||||
| Crypto assets | ||||||||||||||||||||
| Deferred offering costs | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Deposit on investment - Note 4 | ||||||||||||||||||||
| Long-term assets | ||||||||||||||||||||
| Investments, available for sale | ||||||||||||||||||||
| Total long-term assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued legal fees | ||||||||||||||||||||
| Accrued payroll and payroll taxes | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Convertible notes payable, current, net of $1,814,521 and $32,483 debt discount, respectively. $70,000 and $45,000 in default, respectively | ||||||||||||||||||||
| Notes payable, in default | ||||||||||||||||||||
| Notes payable to related party | ||||||||||||||||||||
| Accrued interest payable to related party | ||||||||||||||||||||
| Financing Advance | ||||||||||||||||||||
| Derivative liabilities - convertible instruments | ||||||||||||||||||||
| Due to related parties | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term liabilities | ||||||||||||||||||||
| Convertible notes payable, long-term, net of $880 and $0 debt discount, respectively | ||||||||||||||||||||
| Convertible notes payable to related party, long-term | ||||||||||||||||||||
| Total long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' deficit | ||||||||||||||||||||
| Preferred Stock, Value | ||||||||||||||||||||
| Common Stock, Value | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock, 17,380 shares | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' deficit | ||||||||||||||||||||
| Total liabilities and stockholders' deficit | ||||||||||||||||||||
Loading...
